Navigation Links
British Doctors on Everest Mission Get Bitter Dose

A British team of doctors attempting to conduct tests on Mt Everest,// the highest peak in the world, had to swallow a bitter dose after the Nepal government said the research was illegal.

The Centre for Aviation, Space and Extreme Environment Medicine (CASE) at the University College London had announced in 2005 that it would lead an expedition to the 8,848 m peak in 2007 to measure the amount of oxygen in their own blood on the summit as well as test how well their brains, lungs and metabolisms functioned at extreme altitude.

Led by CASE director Mike Grocott, the research was intended to find out more about the changes in the human body when it is pushed to its limits during critical illness on the basis of the changes that take place in extreme environments.

The Xtreme Everest Expedition, comprising researchers working in the fields of anaesthesia, intensive care and remote medicine, planned to set up laboratories on Mt Everest as it went higher up, with the final one at South Col, at an altitude of 8,000 m.

An offshoot of the experiment, Project Everest, aimed to recruit over 1,000 volunteers to measure their heart rates and breathing at high altitudes in order to come up with fitness programmes in the future.

The team, also including cardiovascular geneticist Hugh Montgomery, physician Sundeep Dhillon, clinician Roger McMorrow, diving expert Denny Levett and space expert Kevin Fong generated worldwide media hype when it announced its plans in 2005. However, there was one thing the doctors forgot - to take the permission of the host country.

According to Nirbhay Kumar Sharma, administrative officer of the Nepal Health Research Council, the apex body overseeing all research conducted in the country:
'"/>




Page: 1

Related medicine news :

1. Designer baby for British couple
2. British Authorities Seize Spurious Drugs
3. Collaborations planned between British Organization and Indian health care industry
4. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
5. British Women Flies to India for Treatment of Breast Cancer
6. Sharp Increase In Morning-After Pill Sales Among British Women
7. British company developing ‘Safer Cigarettes
8. British man Recovered from HIV
9. British medical education suffers shortage of bodies
10. Relief For British MS Patients: Cannabis-Based Oral Spray
11. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: